Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03850600 · ClinicalTrials.gov registry record · NA
Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease
A NA study of Pregnancy and Crohn Disease, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- NA
- Development phase
- 194
- Enrollment target
- 2
- Study locations
NCT03850600 is a NA study of Pregnancy and Crohn Disease that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 194 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03850600, a NA study of Pregnancy and Crohn Disease, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
- 2
- Study locations
Study Summary
The MELODY Trial: Modulating Early Life Microbiome through Dietary Intervention in Crohn's Disease, will test whether a non-invasive dietary intervention during pregnancy can improve the gut microbiota composition in both pregnant Crohn's disease patients and their babies during the sensitive time window of infant immune system development, and whether this can lead to decreased risk of maternal disease relapse postpartum and decreased functional gastrointestinal disorders and gut inflammation in their babies. Through this trial, the study team hopes to better understand the origin of the initial gut bacterial colonization in babies, providing potential intervention targets to prevent Crohn's disease development in high risk individuals.
Conditions Studied
Interventions
- OTHER Diet-CD
Study Locations (2)
Massachusetts
- University of Massachusetts Medical School - Worcester
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03850600
The ClinicalTrials.gov registry entry for NCT03850600 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (78% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Diet-CD is the first listed.
NCT03850600 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT03850600 about?
NCT03850600 is a clinical study titled "Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease". The MELODY Trial: Modulating Early Life Microbiome through Dietary Intervention in Crohn's Disease, will test whether a non-invasive dietary intervention during pregnancy can improve the gut microbiota composition in both pregnant Crohn's disease patients and their babies during the sensitive time w...
What is the current status of trial NCT03850600?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 194 participants. The study started on 2019-01-30. Estimated completion is 2027-11.
What conditions does trial NCT03850600 study?
This clinical trial studies the following conditions: Pregnancy, Crohn Disease.
What interventions are being tested in trial NCT03850600?
The interventions under investigation include: Diet-CD (OTHER).
Who is sponsoring clinical trial NCT03850600?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03850600 being conducted?
This trial has 2 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.